Aclaris Therapeutics Inc

Executive equity grants at Aclaris Therapeutics reveal leadership’s long‑term confidence, signalling potential upside if key clinical milestones and payer deals succeed.

Loerop James’ recent Aclaris Therapeutics buy signals insider confidence amid earnings volatility – what it means for investors.